← Back to Screener
Bio-Techne Corp. (TECH)
Price$51.99
Value ScoreD
Growth ScoreC
Momentum ScoreC
Favorite Metrics
Price vs S&P 500 (26W)-27.33%
Price vs S&P 500 (4W)7.52%
VGM Score43.11
Market Capitalization$8.14B
P/E Ratio (Annual)110.90x
Indicated Dividend Yield (Annual)0.60%
All Metrics
P/CF (Annual)28.31x
Book Value / Share (Quarterly)$13.32
P/TBV (Annual)5.19x
Indicated Dividend (Annual)$0.32
Revenue Growth (3Y)3.33%
Cash Flow / Share (Quarterly)$1.72
Payout Ratio (TTM)29.42%
Price vs S&P 500 (YTD)-19.75%
Gross Margin (TTM)66.42%
Net Profit Margin (TTM)8.96%
EPS (TTM)$0.69
10-Day Avg Trading Volume2.69M
EPS Excl Extra (TTM)$0.69
Revenue Growth (5Y)10.55%
EPS (Annual)$0.46
Dividend / Share (Annual)$0.32
ROI (Annual)3.24%
Gross Margin (Annual)66.50%
Net Profit Margin (5Y Avg)17.06%
Cash / Share (Quarterly)$1.34
P/E Basic Excl Extra (TTM)75.05x
Revenue Growth QoQ (YoY)-1.51%
EPS Growth (5Y)-20.58%
P/E Normalized (Annual)110.90x
ROA (Last FY)2.87%
Revenue Growth TTM (YoY)0.17%
EBITD / Share (TTM)$1.62
ROE (5Y Avg)10.29%
Operating Margin (TTM)12.70%
Cash Flow / Share (Annual)$1.66
P/B Ratio3.90x
P/B Ratio (Quarterly)3.92x
Net Income / Employee (Annual)$23,700
EV / Revenue (TTM)6.71x
Net Interest Coverage (TTM)45.00x
ROA (TTM)4.27%
EPS Growth QoQ (YoY)128.22%
EV / EBITDA (TTM)32.00x
EPS Incl Extra (Annual)$0.46
Current Ratio (Annual)3.46x
Quick Ratio (Quarterly)3.18x
3-Month Avg Trading Volume2.61M
52-Week Price Return7.62%
EV / Free Cash Flow (Annual)31.69x
P/E Incl Extra (TTM)75.05x
Revenue / Employee (TTM)$390,600
Tangible BV / Share (Quarterly)$11.28
P/S Ratio (Annual)6.67x
Asset Turnover (Annual)0.48x
52-Week High$72.16
Operating Margin (5Y Avg)21.83%
EPS Excl Extra (Annual)$0.46
CapEx CAGR (5Y)-9.72%
Tangible BV CAGR (5Y)12.43%
26-Week Price Return-19.41%
Quick Ratio (Annual)2.38x
13-Week Price Return-6.98%
Total Debt / Equity (Annual)0.18x
Current Ratio (Quarterly)4.49x
Enterprise Value$8.13B
Revenue / Share Growth (5Y)10.25%
Asset Turnover (TTM)0.48x
Book Value / Share Growth (5Y)6.63%
Revenue / Employee (Annual)$393,400
Inventory Turnover (Annual)2.21x
Pretax Margin (Annual)8.07%
Cash / Share (Annual)$1.05
3-Month Return Std Dev58.57%
Gross Margin (5Y Avg)67.46%
Net Income / Employee (TTM)$35,000
EBITDA CAGR (5Y)-6.19%
EBITDA Interim CAGR (5Y)2.13%
ROE (Last FY)3.83%
Net Interest Coverage (Annual)27.65x
EPS Basic Excl Extra (Annual)$0.46
P/FCF (TTM)30.19x
Receivables Turnover (TTM)5.36x
EV / Free Cash Flow (TTM)30.16x
Total Debt / Equity (Quarterly)0.10x
EPS Incl Extra (TTM)$0.69
Receivables Turnover (Annual)5.44x
ROI (TTM)4.77%
Dividend Growth Rate (5Y)0.11%
P/S Ratio (TTM)6.72x
Pretax Margin (5Y Avg)19.41%
Revenue / Share (Annual)$7.64
Tangible BV / Share (Annual)$10.02
Forward P/E25.37x
Free OCF CAGR (5Y)10.82%
Price vs S&P 500 (52W)-16.75%
P/E Ratio (TTM)75.05x
EPS Growth TTM (YoY)-15.90%
Year-to-Date Return-11.60%
5-Day Price Return2.36%
EPS Normalized (Annual)$0.46
ROA (5Y Avg)7.59%
Net Profit Margin (Annual)6.02%
Month-to-Date Return0.60%
Cash Flow / Share (TTM)$2.20
EBITD / Share (Annual)$0.84
EPS Growth (3Y)-34.80%
Operating Margin (Annual)8.38%
LT Debt / Equity (Annual)0.18x
P/CF (TTM)27.61x
ROI (5Y Avg)8.77%
P/E Excl Extra (TTM)75.05x
LT Debt / Equity (Quarterly)0.10x
EPS Basic Excl Extra (TTM)$0.69
P/TBV (Quarterly)4.63x
Payout Ratio (Annual)68.65%
P/B Ratio (Annual)4.20x
Dividend / Share (TTM)$0.32
Inventory Turnover (TTM)2.07x
Pretax Margin (TTM)12.06%
Book Value / Share (Annual)$12.38
Price vs S&P 500 (13W)-15.23%
Net Margin Growth (5Y)-27.97%
Dividend Yield (TTM)0.61%
Beta1.34x
P/FCF (Annual)31.73x
Revenue / Share (TTM)$7.69
ROE (TTM)5.44%
52-Week Low$43.20
vGradeD
gGradeC
mGradeC
vgmGradeC
Show chart for
Earnings Surprise History
Q3 260.53est. 0.55
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.09
4.04
4.04
4.04
Industry Peers — Biological Products(178)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
TECHBio-Techne Corp. | D | C | C | $51.99 |
| AMGNAmgen Inc | C | C | C | $349.58 |
| GILDGilead Sciences Inc | C | B | C | $129.16 |
| ARGXargenx SE American Depositary Shares | D | A | B | $891.32 |
| RVMDRevolution Medicines, Inc. Common Stock | F | — | A | $149.23 |
| BIIBBiogen Inc. Common Stock | B | D | B | $195.34 |
| BNTXBioNTech SE American Depositary Share | C | C | D | $88.08 |
| MRNAModerna, Inc. Common Stock | C | B | B | $47.44 |
| NBIXNeurocrine Biosciences Inc | C | B | B | $163.88 |
| EXELExelixis Inc | C | B | B | $52.70 |
| KRYSKrystal Biotech, Inc. Common Stock | D | B | A | $301.00 |
About
Bio-Techne is a life sciences manufacturer providing consumables and instruments to pharmaceutical, biotech, academic, and diagnostic markets through two segments: protein sciences (75% of revenue), supplying reagents and analytical instruments including antibodies for protein analysis, and diagnostics and genomics (25%), offering diagnostic reagents, molecular diagnostics, and spatial biology products. The company generates approximately 55% of revenue from the United States, with the remainder from Europe, Asia-Pacific, and other international markets. This diversified product portfolio and geographic footprint position the company to serve multiple end-markets within the life sciences research and diagnostic sectors.